pyrazines has been researched along with t 1105 in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Barnard, DL; Furuta, Y; Gowen, BB; Julander, JG; Morrey, JD; Sakamoto, K; Shiraki, K; Smee, DF; Takahashi, K | 1 |
Billiet, A; De Clercq, K; De Vleeschauwer, AR; Goris, N; Lefebvre, DJ; Murao, LE; Neyts, J; Paul, G; Willems, T | 1 |
Bei, Z; Cai, L; Dou, Y; Song, Y; Sun, Y; Wang, H; Xu, L; Zhang, D | 1 |
Bonnac, LF; Geraghty, RJ; Patterson, SE; Qiu, L | 1 |
Huchting, J; Meier, C; Naesens, L; Nasser, H; Vanderlinden, E; Winkler, M | 1 |
Huchting, J; Meier, C; Naesens, L; Van Berwaer, R; Vanderlinden, E | 1 |
Canard, B; Coutard, B; Decroly, E; Fattorini, V; Ferron, F; Huchting, J; Le, NT; Meier, C; Peersen, O; Piorkowski, G; Selisko, B; Shannon, A; Touret, F | 1 |
Chen, YC; Ho, YJ; Huang, CK; Lin, KC; Lu, JW | 1 |
Bonnac, LF; Cheeran, MC; Dreis, CD; Edwards, TC; Geraghty, RJ; Krishna, VD; Qiu, L; Soto-Acosta, R; Xie, J | 1 |
Fukai, K; Furuta, Y; Ikezawa, M; Kawaguchi, R; Komeno, T; Kurosaki, C; Masujin, K; Morioka, K; Nakajima, N; Nishi, T; Sakamoto, K; Sugihara, H; Yamada, M | 1 |
1 review(s) available for pyrazines and t 1105
Article | Year |
---|---|
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
Topics: Amides; Animals; Antiviral Agents; Nucleosides; Pyrazines; RNA Virus Infections; RNA Viruses; RNA-Dependent RNA Polymerase; Viral Proteins | 2009 |
9 other study(ies) available for pyrazines and t 1105
Article | Year |
---|---|
A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Disease Models, Animal; Europe; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guinea Pigs; Pyrazines; RNA, Viral; Vaccination; Viral Vaccines | 2016 |
Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
Topics: Amides; Animals; Antiviral Agents; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Molecular Structure; Pyrazines; Vero Cells; Virus Replication; Zika Virus | 2017 |
Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
Topics: Amides; Antiviral Agents; Dengue; Dengue Virus; Humans; Mutagenesis; Mutation; Nucleosides; Pyrazines; Virus Replication | 2018 |
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
Topics: Amides; Animals; Antiviral Agents; Dogs; Madin Darby Canine Kidney Cells; Orthomyxoviridae; Prodrugs; Pyrazines; Ribonucleotides | 2018 |
Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir).
Topics: Amides; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Dogs; HEK293 Cells; Humans; Madin Darby Canine Kidney Cells; Pyrazines; Ribonucleosides; RNA Viruses; Vero Cells | 2019 |
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.
Topics: Amides; Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Models, Molecular; Mutagenesis; Pandemics; Pneumonia, Viral; Pyrazines; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Sequence Analysis; Vero Cells; Viral Nonstructural Proteins; Virus Replication | 2020 |
Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection.
Topics: Anidulafungin; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Synergism; Humans; Inhibitory Concentration 50; Pyrazines; RNA, Viral; Vero Cells; Virion; Virus Attachment; Zika Virus; Zika Virus Infection | 2021 |
Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies.
Topics: Adenosine Triphosphate; Amides; Animals; Antimetabolites; Antiviral Agents; Cell Line; Drug Synergism; Guanosine Triphosphate; Humans; Methylthioinosine; Mutation; Phosphoribosyl Pyrophosphate; Pyrazines; RNA Viruses; RNA, Viral; Virus Replication | 2021 |
Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infection.
Topics: Animals; Antiviral Agents; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Pyrazines; Swine | 2022 |